- Home
- BNZI vs PPBT Comparison
BNZI vs PPBT Comparison
Compare BNZI & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- PPBT
- Stock Information
- Founded
- BNZI 2016
- PPBT 2010
- Country
- BNZI United States
- PPBT Israel
- Employees
- BNZI N/A
- PPBT N/A
- Industry
- BNZI
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- PPBT Health Care
- Exchange
- BNZI Nasdaq
- PPBT Nasdaq
- Market Cap
- BNZI 11.5M
- PPBT 6.2M
- IPO Year
- BNZI N/A
- PPBT N/A
- Fundamental
- Price
- BNZI $3.87
- PPBT $2.53
- Analyst Decision
- BNZI Strong Buy
- PPBT Strong Buy
- Analyst Count
- BNZI 1
- PPBT 1
- Target Price
- BNZI $24.00
- PPBT $33.00
- AVG Volume (30 Days)
- BNZI 477.6K
- PPBT 18.2K
- Earning Date
- BNZI 08-13-2025
- PPBT 08-15-2025
- Dividend Yield
- BNZI N/A
- PPBT N/A
- EPS Growth
- BNZI N/A
- PPBT N/A
- EPS
- BNZI N/A
- PPBT N/A
- Revenue
- BNZI $6,827,490.00
- PPBT N/A
- Revenue This Year
- BNZI $337.60
- PPBT N/A
- Revenue Next Year
- BNZI $91.81
- PPBT N/A
- P/E Ratio
- BNZI N/A
- PPBT N/A
- Revenue Growth
- BNZI 52.95
- PPBT N/A
- 52 Week Low
- BNZI $3.80
- PPBT $2.00
- 52 Week High
- BNZI $112.00
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- BNZI 24.22
- PPBT 56.04
- Support Level
- BNZI $3.93
- PPBT $2.35
- Resistance Level
- BNZI $6.90
- PPBT $2.58
- Average True Range (ATR)
- BNZI 0.63
- PPBT 0.12
- MACD
- BNZI -0.12
- PPBT 0.02
- Stochastic Oscillator
- BNZI 2.12
- PPBT 84.38
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.